Delaware
|
87-0267438
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02 |
Results of Operations and Financial Condition.
|
Item 9.01 |
Financial Statements and Exhibits.
|
(d) |
Exhibits.
|
Exhibit
No.
|
Description
|
|
Press Release dated March 30, 2015 (a)
|
||
Press Release dated May 14, 2015 (a)
|
||
Press Release dated August 14, 2015 (a)
|
||
Press Release dated November 16, 2015 (a)
|
||
Press Release dated March 30, 2016 (a)
|
||
Press Release dated May 13, 2016 (a)
|
||
Press Release dated August 12, 2016 (a)
|
(a) |
The exhibits relating to Item 2.02 are intended to be furnished to, not filed with, the U.S. Securities and Exchange Commission pursuant to General Instruction B.2 of Form 8-K.
|
TENGASCO, INC.
|
||
By:
|
/s/ Michael J. Rugen
|
|
Name:
|
Michael J. Rugen
|
|
Title:
|
Chief Executive Officer
|
Year Ended
|
||||
December 31, 2014
|
||||
Net loss from continuing operations (US GAAP)
|
$
|
(0.8
|
)
|
|
Impairment, net of tax
|
$
|
1.7
|
||
Net income from continuing operations before effect of impairment
|
$
|
0.9
|
||
Net loss per share from continuing operations – basic and diluted (US GAAP)
|
$
|
(0.01
|
)
|
|
Impairment, net of tax per share – basic and diluted
|
$
|
0.03
|
||
Net income per share from continuing operations before effect of impairment – basic and diluted
|
$
|
0.02
|
Quarter Ended
|
Nine Months Ended
|
|||||||
September 30, 2015
|
September 30, 2015
|
|||||||
Net loss from continuing operations (US GAAP)
|
$
|
(5.0
|
)
|
$
|
(5.6
|
)
|
||
Impairment, net of tax
|
$
|
4.4
|
$
|
4.4
|
||||
Net loss before effect of impairment
|
$
|
(0.6
|
)
|
$
|
(1.2
|
)
|
||
Net loss per share – basic and diluted (US GAAP)
|
$
|
(0.08
|
)
|
$
|
(0.09
|
)
|
||
Impairment, net of tax per share – basic and diluted
|
$
|
0.07
|
$
|
0.07
|
||||
Net loss per share before effect of impairment – basic and diluted
|
$
|
(0.01
|
)
|
$
|
(0.02
|
)
|
Year Ended December 31, 2015
|
||||
Net loss (US GAAP)
|
$
|
(24.7
|
)
|
|
Impairment
|
$
|
14.5
|
||
Valuation allowance
|
$
|
7.3
|
||
Net income from continuing operations before effect of impairment
|
$
|
(2.9
|
)
|
|
Net loss per share – basic and diluted (US GAAP)
|
$
|
(4.06
|
)
|
|
Impairment – basic and diluted
|
$
|
2.38
|
||
Valuation allowance – basic and diluted
|
$
|
1.21
|
||
Net income per share before effect of impairment and valuation allowance – basic and diluted
|
$
|
(0.47
|
)
|
Quarter Ended
|
||||
March 31, 2016
|
||||
Net loss from continuing operations (US GAAP)
|
$
|
(1,404
|
)
|
|
Impairment
|
$
|
641
|
||
Net loss before effect of impairment
|
$
|
(763
|
)
|
|
Net loss per share – basic and diluted (US GAAP)
|
$
|
(0.23
|
)
|
|
Impairment, net of tax per share – basic and diluted
|
$
|
0.10
|
||
Net loss per share before effect of impairment – basic and diluted
|
$
|
(0.13
|
)
|
Quarter Ended
|
Six Months Ended
|
|||||||
June 30, 2016
|
June 30, 2016
|
|||||||
Net loss from continuing operations (US GAAP)
|
$
|
(1.6
|
)
|
$
|
(3.0
|
)
|
||
Impairment
|
$
|
1.4
|
$
|
2.1
|
||||
Net loss before effect of impairment
|
$
|
(0.2
|
)
|
$
|
(0.9
|
)
|